Instrument Inactif

Autres langues STALLERGENES

Actions

FR0000065674

Cours en clôture Euronext Paris Autres places de cotation
- ^EUR	-

2017	Stallergenes Greer : des objectifs rassurants.	CF
2017	Les valeurs à suivre aujourd'hui à la Bourse de Paris - Jeudi 30 mars 2017	AO

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

STALLERGENES : GREER ANNOUNCES ITS 2016 FINANCIAL CALENDAR	22/02/16
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS & EXECUTIVE VP HEAD OF EUROPE & ROW	10/02/16
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS AND EXECUTIVE VP, HEAD OF EUROPE & REST OF WORLD	10/02/16
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS AND EXECUTIVE VICE PRESIDENT, HEAD OF EUROPE & REST OF WORLD	10/02/16
STALLERGENES : GREER ANNOUNCES RESUMPTION OF MANUFACTURING AT ITS ANTONY PLANT	01/02/16
STALLERGENES : TIBOR NEMES APPOINTED GLOBAL HEAD OF TECHNICAL OPERATIONS	01/02/16
STALLERGENES : RECALL OF ALLERGY IMMUNOTHERAPY PRODUCTS	07/12/15
STALLERGENES : ANNOUNCES THE LAUNCH OF ACTAIR® IN JAPAN	19/11/15
STALLERGENES : Michele Antonelli appointed as Executive Vice President, Head of International Operations	10/11/15
STALLERGENES : Introducing a new global allergy company	10/11/15
STALLERGENES : Ares Allergy Holdings plc becomes Stallergenes Greer plc	10/11/15
STALLERGENES : Development of our House Dust Mite sublingual immunotherapy tablet	10/11/15
Stallergenes : is pleased to see the mobile allergen exposure chamber at the 2015 EAACI congress, Barcelona	08/06/15
Stallergenes : continues its international expansion with the opening of an affiliate in Canada.	24/10/14
Stallergenes : sales reach €45.7 million in Q3 2014; Oralair® achieves market leadership in France; Continued expansion of international markets (up 33%)	23/10/14
DBV TECHNOLOGIES : French developer of 'peanut allergy patch' makes U.S. debut	22/10/14
STALLERGENES : Half-year revenues and results	24/07/14
Stallergenes : welcomes Fleur Pellerin, Secretary of State for Foreign Trade to its principal site in Antony, Hauts-de-Seine, France.	08/07/14
Stallergenes : to be present at the 3rd annual Citi European healthcare conference on June 20, 2014	06/06/14
STALLERGENES : Industrial consortium announces its support for GA²LEN’s developement of mobile environmental exposure chambers	08/05/14

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues STALLERGENES

Actions

FR0000065674

Autres langues

Filtres